Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides. (Q50850165)

From Wikidata
Jump to navigation Jump to search
scientific article published on 3 May 2014
edit
Language Label Description Also known as
English
Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides.
scientific article published on 3 May 2014

    Statements

    Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit